More evidence needed on pharmacologic therapy alone and combined with gait training
Cannabinoid oromucosal spray is poised for FDA submission in 2021
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy